Ventyx Biosciences (VTYX) Competitors $2.37 +0.12 (+5.33%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VTYX vs. CRGX, EXAI, ORIC, TERN, VECT, TRML, PHAT, PROK, DNA, and ANNXShould you be buying Ventyx Biosciences stock or one of its competitors? The main competitors of Ventyx Biosciences include CARGO Therapeutics (CRGX), Exscientia (EXAI), ORIC Pharmaceuticals (ORIC), Terns Pharmaceuticals (TERN), VectivBio (VECT), Tourmaline Bio (TRML), Phathom Pharmaceuticals (PHAT), ProKidney (PROK), Ginkgo Bioworks (DNA), and Annexon (ANNX). These companies are all part of the "pharmaceutical products" industry. Ventyx Biosciences vs. CARGO Therapeutics Exscientia ORIC Pharmaceuticals Terns Pharmaceuticals VectivBio Tourmaline Bio Phathom Pharmaceuticals ProKidney Ginkgo Bioworks Annexon Ventyx Biosciences (NASDAQ:VTYX) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings, risk and community ranking. Do analysts recommend VTYX or CRGX? Ventyx Biosciences currently has a consensus price target of $10.00, indicating a potential upside of 321.94%. CARGO Therapeutics has a consensus price target of $31.80, indicating a potential upside of 115.45%. Given Ventyx Biosciences' higher possible upside, analysts clearly believe Ventyx Biosciences is more favorable than CARGO Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ventyx Biosciences 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80CARGO Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in VTYX or CRGX? 97.9% of Ventyx Biosciences shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 18.2% of Ventyx Biosciences shares are held by insiders. Comparatively, 1.4% of CARGO Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community believe in VTYX or CRGX? Ventyx Biosciences received 17 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 47.69% of users gave Ventyx Biosciences an outperform vote. CompanyUnderperformOutperformVentyx BiosciencesOutperform Votes3147.69% Underperform Votes3452.31% CARGO TherapeuticsOutperform Votes14100.00% Underperform VotesNo Votes Is VTYX or CRGX more profitable? CARGO Therapeutics' return on equity of -38.16% beat Ventyx Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Ventyx BiosciencesN/A -54.94% -50.01% CARGO Therapeutics N/A -38.16%-33.94% Does the media refer more to VTYX or CRGX? In the previous week, CARGO Therapeutics had 1 more articles in the media than Ventyx Biosciences. MarketBeat recorded 4 mentions for CARGO Therapeutics and 3 mentions for Ventyx Biosciences. Ventyx Biosciences' average media sentiment score of 0.78 beat CARGO Therapeutics' score of 0.52 indicating that Ventyx Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ventyx Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CARGO Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Which has preferable earnings & valuation, VTYX or CRGX? CARGO Therapeutics is trading at a lower price-to-earnings ratio than Ventyx Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVentyx BiosciencesN/AN/A-$192.96M-$2.36-1.00CARGO TherapeuticsN/AN/A-$98.15M-$4.26-3.46 SummaryVentyx Biosciences and CARGO Therapeutics tied by winning 7 of the 14 factors compared between the two stocks. Ad Porter & CompanyHow to piss off your liberal friends… and profit from itElon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Get Ventyx Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for VTYX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VTYX vs. The Competition Export to ExcelMetricVentyx BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$167.58M$6.86B$5.17B$9.32BDividend YieldN/A3.06%4.78%4.06%P/E Ratio-1.0010.75127.7717.55Price / SalesN/A285.811,261.39139.05Price / CashN/A56.6541.0437.95Price / Book0.575.394.894.92Net Income-$192.96M$151.81M$119.40M$225.78M7 Day Performance-14.75%-5.54%14.54%-1.47%1 Month Performance26.74%0.33%17.43%5.36%1 Year Performance5.33%16.04%35.31%22.71% Ventyx Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VTYXVentyx Biosciences3.229 of 5 stars$2.37+5.3%$10.00+321.9%+5.3%$167.58MN/A-1.0073News CoverageCRGXCARGO Therapeutics1.8446 of 5 stars$13.98+1.7%$31.80+127.5%-18.7%$643.47MN/A-3.23116EXAIExscientia1.2867 of 5 stars$4.84+3.2%$7.00+44.6%-17.5%$632.93M$25.60M-3.21280High Trading VolumeORICORIC Pharmaceuticals3.775 of 5 stars$8.45-0.8%$18.29+116.4%-11.4%$596.32MN/A-4.6880Insider TradeNews CoveragePositive NewsGap DownTERNTerns Pharmaceuticals4.2241 of 5 stars$6.97+3.6%$18.30+162.6%+7.1%$592.03M$1M-5.7040VECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030TRMLTourmaline Bio2.1359 of 5 stars$22.34+2.4%$54.00+141.7%+9.3%$572.87MN/A-7.7344PHATPhathom Pharmaceuticals2.9256 of 5 stars$8.34+5.7%$23.00+175.8%-4.0%$570.29M$680,000.00-1.48110Gap UpPROKProKidney2.3102 of 5 stars$1.92+6.7%$4.50+135.0%+3.9%$558.53MN/A-3.553Positive NewsDNAGinkgo Bioworks0.7441 of 5 stars$9.65+2.2%$4.58-52.6%N/A$554.68M$251.46M-0.721,218News CoveragePositive NewsANNXAnnexon2.4011 of 5 stars$5.18+16.7%$15.80+205.0%+74.9%$552.16MN/A-4.9060Analyst ForecastNews Coverage Related Companies and Tools Related Companies CARGO Therapeutics Competitors Exscientia Competitors ORIC Pharmaceuticals Competitors Terns Pharmaceuticals Competitors VectivBio Competitors Tourmaline Bio Competitors Phathom Pharmaceuticals Competitors ProKidney Competitors Ginkgo Bioworks Competitors Annexon Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VTYX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ventyx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ventyx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.